UK Medicines Information
Tofacitinib for moderate to severe rheumatoid arthritis – guidance (TA480)
Information type:
Guidance
Source:
National Institute for Health and Care Excellence
Specialities:
Musculo-skeletal disorders
Summary
NICE has published evidence based recommendations on tofacitinib (Xeljanz) for treating moderate to severe rheumatoid arthritis in adults.
UKMi comment
Related links: